Literature DB >> 27005336

[External validation of the short emergency geriatric assessment (SEGA) instrument on the SAFES cohort].

Émilie Tardieu1, Rachid Mahmoudi2, Jean-Luc Novella2, Nadia Oubaya3, François Blanchard2, Damien Jolly4, Moustapha Dramé4.   

Abstract

The aim of the study was to achieve the external validation of the SAGA instrument on the SAFES cohort. This was a prospective longitudinal multicentre cohort study, including patients aged 75 years or over, hospitalized in a short stay medical ward via emergency department. A comprehensive geriatric assessment was implemented. The psychometric validation enabled the study of feasibility, internal consistency, convergent, discriminant, and predictive validity of the instrument. The 1 306 patients of the cohort was 85±6 years, with a majority of women (65%). The completion rate of the SEGA instrument was 94%. Internal consistency was good (Cronbach alpha coefficient=0.7). Convergent validity was poor: Donini instrument (kappa=0.18; IC 95%=0.13-0.23), Rockwood instrument (kappa=0.04; IC 95%=0.02-0.06), and Winograd instrument (kappa=0.04; IC 95%=0.01-0.07). The ability of the instrument to discriminate clinically different groups was good. The SEGA instrument predicted well one-year mortality as well as one-year institution admission. Despite poor convergent validity (which is classic with frailty tools, SEGA instrument has satisfactory metrological properties, allowing its use in emergency departments and immediate post-emergency circumstances.

Entities:  

Keywords:  SEGA instrument; elderly people; emergency department; psychometric validation

Mesh:

Year:  2016        PMID: 27005336     DOI: 10.1684/pnv.2016.0592

Source DB:  PubMed          Journal:  Geriatr Psychol Neuropsychiatr Vieil        ISSN: 2115-7863


  1 in total

1.  Pilot Site Deployment of an IoT Solution for Older Adults' Early Behavior Change Detection.

Authors:  Hamdi Aloulou; Mounir Mokhtari; Bessam Abdulrazak
Journal:  Sensors (Basel)       Date:  2020-03-29       Impact factor: 3.576

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.